title: Synthesis of (+/-)- and (-)-vibralactone and vibralactone C.
abstract: Mander reductive alkylation of methyl 2-methoxybenzoate with prenyl bromide and hydrolysis of the enol ether afforded methyl 6-oxo-1-prenyl-2-cyclohexenecarboxylate. This was converted in five steps (reduction of the ketone, saponification, iodolactonization, ozonolysis, and intramolecular aldol reaction) to a spiro lactone cyclopentenal. An efficient first synthesis of (+/-)-vibralactone was completed by retro-iodolactonization with activated Zn, formation of the beta-lactone (vibralactone C), and reduction of the aldehyde. Except for the novel use of an iodolactone to protect both the prenyl double bond and carboxylic acid, no protecting groups were used. A similar sequence starting with asymmetric reductive alkylation of the (2S)-2-methoxymethoxymethylpyrrolidine amide of 2-methoxybenzoic acid with prenyl bromide afforded (-)-vibralactone confirming the absolute stereochemical assignment that was based on computational methods.
authors.affiliation: Department of Chemistry MS 015, Brandeis University, Waltham, Massachusetts 02454-9110, USA.
authors.forename: Quan
authors.initials: Q
authors.lastname: Zhou
authors.forename: Barry B
authors.initials: BB
authors.lastname: Snider
mesh_terms: D000478:Alkylation; D062425:Hydroxybenzoate Ethers; D007783:Lactones / Q000138:chemical synthesis* / Q000737:chemistry; D012459:Salicylates / Q000737:chemistry; D013237:Stereoisomerism
chemical_list: D062425:Hydroxybenzoate Ethers; D007783:Lactones; D012459:Salicylates; C522315:vibralactone; C534371:vibralactone C; C081914:2-methoxybenzoic acid
references.citation: J Org Chem. 2007 Feb 2;72(3):930-7
references.pmid: 17253813
references.citation: J Med Chem. 2005 Jun 2;48(11):3684-7
references.pmid: 15916417
references.citation: Org Lett. 2008 Apr 3;10(7):1401-4
references.pmid: 18311992
references.citation: Science. 1995 May 5;268(5211):726-31
references.pmid: 7732382
references.citation: Org Lett. 2006 Dec 7;8(25):5749-52
references.pmid: 17134263
references.citation: J Am Chem Soc. 2007 Aug 29;129(34):10346-7
references.pmid: 17672468
references.citation: Org Lett. 2006 Nov 23;8(24):5501-4
references.pmid: 17107057
references.citation: J Org Chem. 2006 Jul 21;71(15):5748-51
references.pmid: 16839158
references.citation: Chem Pharm Bull (Tokyo). 2008 Sep;56(9):1286-8
references.pmid: 18758102
references.citation: J Org Chem. 1998 Apr 17;63(8):2426-2427
references.pmid: 11672097
references.citation: Chem Commun (Camb). 2005 Apr 14;(14):1906-8
references.pmid: 15795783
references.citation: J Org Chem. 1999 Nov 26;64(24):8794-8800
references.pmid: 11674781
references.citation: J Org Chem. 2004 Oct 29;69(22):7728-33
references.pmid: 15498003
references.citation: Drug Discov Today. 2007 Oct;12(19-20):879-89
references.pmid: 17933690